◆ 会议时间：2025年10月20-23日
◆ 会议地点：荷兰 阿姆斯特丹

◆ 会议简介：

2025年第57届国际儿科肿瘤学会年会(SIOP)年会将于2025年10月20-23日在荷兰阿姆斯特丹举行，会议由国际儿科肿瘤学会(SIOP)主办。SIOP年会将汇集世界一流的临床医生和科学家，共同分享探讨儿科肿瘤学领域最新重大科学进展，预计有来自世界各地的1800余名专业人士参会。

国际儿科肿瘤学会(SIOP)成立于20世纪60年代末，是唯一完全致力于儿童和青少年癌症预防、诊断与治疗的全球性多学科学会。SIOP现在世界各地拥有1000多名成员，包括医生、护士、科学家、研究人员和其他卫生保健专业人员，成员们都致力于增加有关儿童癌症各方面的科学知识。SIOP的使命是为全球的患者和家属提供支持，确保每个儿童和青少年癌症患者都能获得最先进的诊断、治疗和护理；通过会议、网络和持续专业发展的教育服务，为全世界所有儿童和青少年癌症护理提供者提供培训机会，为他们提供最新的临床和科学进展信息；通过宣促进和推进基础、临床和其他研究，并通过支持合作与转化科学发现来改善儿童和青少年癌症患者的预后；支持关心儿童和青少年癌症患者，为他们提供最好的治疗和姑息疗法。SIOP的愿景是不让一个孩子因癌症而离去。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

SIOP 2025 - 57th Congress of the International Society of Paediatric Oncology

Date: October 20-23, 2025
Venue: RAI Amsterdam (Amsterdam, the Netherlands)

下为上届信息

摘要征文投稿：

• Abstract Submission Opens:  December 2023
• Abstract Submission Deadline:  Wednesday, Apil 3, 2024 (midnight CET)
• Abstract Notification:  end of June, 2024
• Late Breaking Abstract Submission Period:  Jun 15 – Aug 14, 2024 *

点此提交摘要>>>Submit Abstract>>>

RULES FOR SUBMISSION

Please read the submission rules before submitting an abstract.

• Abstracts must be submitted online via the website only.
  ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
• Presentation Type: Abstracts may be submitted for Oral or Poster. (Late breaking submission will be submitted ONLY for Oral pretension.)
• All presenters must be IN PERSON in Hawaii. SIOP 2024 will NOT offer any pre-recorded\ virtual presentations.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
• Previous Publications of an Abstract – the work must not have been previously accepted by, or published in a peer reviewed journal at the time of abstract submission
• Previous Presentation of an Abstract – the work must not have been previously  presented at a meeting of any other scientific organization with more than 500 attendees prior to the SIOP congress

LIMITATIONS

• Prospective multicenter trials as well as presentation of large translational works are considered as major quality criteria. Inter-diseases sessions (such as target, pathway or immunology oriented) will be planned.
• Case reports and small institutional series of limited added scientific value are not encouraged.
• Clinical Trials in Progress Abstracts cannot be submitted
• Shell Abstracts (abstracts that provide no data) cannot be submitted
  A shell abstract is one that intends to have data but the data are either not collected yet or analyzed yet. Qualitative data are appropriate to submit.
• The same person may submit up to 5 abstracts regardless of presenting author.
• The same person may serve as presenting author on up to 5 abstracts.
• Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees by the date indicated in the notification email will be scheduled for presentation and included for publication.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Congress publications.
• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.
• Abstracts must be submitted in English.
  All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. Authors who would like assistance with the English writing of their abstract, should contact us at siop_abstracts@kenes.com at least 2 weeks prior the deadline.
• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.
• Instructions for preparation of presentations will be made available on the congress website.
• All accepted abstracts that their presenting author has registered by the deadline indicated in the notification email will be published in the Pediatric Blood and Cancer (PBC) online supplement.

GUIDELINES FOR SUBMISSION

​Before you begin, please prepare the following information:

• ​Presenting author’s contact details:
  – Full first and family name(s)
  – Email address
  – Affiliation details: department, institution / hospital, city state (if relevant), Country
  – Phone number
• Author and co-authors’ details
• Preferred Presentation type: Oral Presentation/Poster
• Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words.
• Abstract text – limited to 300 words including acknowledgements.
• Abstract topic– select the abstract topic per the list of topics.
• Text only is to be submitted. Tables, figures and bulleted text are not permitted.
• Abstracts should clearly state:
  Background and aims
  Methods
  Results
  Conclusions 
• Use only standard abbreviations. Abbreviations must be consistent with instructions to authors of the Pediatric Blood & Cancer Journal and be defined on 1st usage, then use of abbreviation alone is OK, i.e. Wilms Tumor (WT), then referred to as “WT” in subsequent mention. Please use as few abbreviations as possible and only commonly used abbreviations.
• Disease names should be written without apostrophes, for example: Wilms tumour, Burkitt lymphoma, Hodgkin disease, etc. Please do not refer to patients by their diseases, e.g. ‘Wilms tumour patients’ or ALL patients’. Instead identify them as ‘patients with Wilms tumour; and ‘patients with ALL’.
• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.
• Submissions may not contain patient names, hospital ID numbers or other identifying information.
• Numbers over 999 must include a comma, e.g., 2,000.
• Decimal points must be displayed as periods (4.89) not commas (4,89).
• Numbers beginning with a decimal point should be preceded by a zero.
• Periods should be used in numbers for decimal points, not commas, i.e. P=0.015
• All measurements must be in metric units.
• Do not begin sentences with a number – type the number in full, for example, it should be ‘Three patients….’ Instead of ‘3 patients….’.
• Do not use expressions such as ‘On the other hand……’; ‘This is the first study….’; ‘To our knowledge…..’; ‘This is the largest….’.
• Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
• Click on the SUBMIT button at the end of the process in order to save your abstract. You may log in to the system later to make changes to your abstract, up to the submission deadline. After the deadline, changes will not be possible.
• You will receive an abstract reference number via email after you have submitted your abstract. Please refer to this abstract number in all correspondence regarding the abstract.
• Please contact us at siop_abstracts@kenes.com if you have not received confirmation that your abstract has been submitted.
• Please do not submit multiple copies of the same abstract.

ABSTRACT SUBMITTERS’ DECLARATION

During abstract submission you will be asked to confirm that you agree to the following:

• I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published as submitted.
• Submission of the abstract constitutes the consent of all authors to publication (e.g. Congress website, programs, other promotions, etc.)
• The Abstract Submitter warrants and represents that no part of the information and content provided by him/her (Hereafter: the “Content“) to SIOP 2024 and Kenes International (Hereafter: the “Organizers“), nor the publication of any such Content by the Organizers, on the internet or otherwise infringes any third party rights, including but not limited to privacy rights and/or intellectual property rights.
• The Abstract Submitter grants the Organizers a copyright license to reproduce, publish, translate, distribute, and display the text of the Content on a royalty-free, perpetual, irrevocable nonexclusive basis.
• I herewith confirm that the contact details saved in this system are those of the presenting author, who will be notified about the status of the abstract. The presenting author is responsible for informing the other authors about the status of the abstract. The submitting author may request to be copied on abstract correspondence.
• I understand that the presenting author must be a registered participant.
• The Organizers reserve the right to remove from publication and/or presentation an abstract which does not comply with the above.
• I understand that I must select a specific Theme, Topic and/or Sub-Topic for my abstract allocation.  Although the Committee will work hard to honor this selection, this cannot be guaranteed.  The Committee reserves the right to change the Theme, Topic or Sub-Topic under which the abstract was originally submitted.

SELECTION PROCESS

All abstracts will be evaluated anonymously and scored by the appropriate Scientific Programme Advisory Working Group members. The Scientific Committee will determine whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
The Scientific Committee will determine If accepted as:

• an oral presentation;
• a poster presentation, possibly with a poster session participation or special Scientific Committee mention;
• a journal publication

LATE BREAKING ABSTRACTS

Recognizing that the results of some high impact research may not be available by the general abstract submission deadline, SIOP offers an option for late breaking abstracts.

Please read the submission rules before submitting a late breaking abstract.

• The late breaking abstracts are reserved for highly relevant, impactful research whereby the data became available in the last three months.
• Only three Oral abstracts will be selected.
• Retrospective or single center studies are typically not competitive.
• This is NOT a deadline extension of the general abstract submission deadline.

Dear Friends and Colleagues,

I am delighted to extend a warm and heartfelt welcome to you as we gather in Hawaii, USA, for the 56th Annual SIOP Congress. It is with great enthusiasm that we anticipate yet another exceptional congress, and our Local Organising Committee, under the able leadership of Dr. Wade Kyono, is dedicated to ensuring a memorable experience in this extraordinary setting.

The Scientific Committee has diligently curated a program of unparalleled quality, featuring internationally acclaimed speakers and a diverse range of symposium topics designed to captivate and engage all participants.

In light of the unique circumstances we continue to navigate, I would like to inform you that this year’s congress will not offer a hybrid meeting format. The financial implications of such an arrangement post-COVID are regrettably prohibitive for our society. However, we understand the challenges many of our colleagues face in attending the SIOP Congress, and we are committed to providing session recordings for on-demand access. Moreover, we will collaborate with our continental branches to offer interactive activities based on these recordings.

As part of our ongoing commitment to support young professionals in low and middle-income countries, we are pleased to announce the availability of scholarships tailored for the Young SIOP group. I encourage all eligible individuals to apply for these scholarships and ensure that you persue your United States entry visa well in advance if needed.

The SIOP 2024 annual congress in Hawaii marks an exciting milestone for our organisation. Being situated in the United States, we anticipate valuable contributions from our North American colleagues and institutions, such as the Children’s Oncology Group. Simultaneously, the congress’s proximity to South-East Asia and Oceania promises to infuse our event with the expertise and insights of these dynamic regions. We are excited to come together to savour the unique charm of Hawaii as a destination.

As always, our scientific programme will encompass a range of global paediatric oncology topics, with a particular focus on research conducted by the cooperative groups participating in the PARC programme. We are developing a robust agenda that addresses global health-related subjects and explores updates related to the WHO Global Initiative on Childhood Cancer, where SIOP is recognised as a non-state actor.

The SIOP Congress continues to grow year by year, not only due to the academic excellence of our sessions but also because it offers a global platform for networking, knowledge-sharing, and collaboration in a relaxed and welcoming atmosphere.

We eagerly await your presence at SIOP 2024 in Hawaii, and we encourage you not to miss this unique opportunity to stay at the forefront of the latest developments in your field. Your participation and contributions are invaluable to the success of our congress, and we look forward to creating memorable moments together.

Warm regards,
Guillermo Luis Chantada,
SIOP President

注册费：

Registration fees (in USD):
Fees apply to payments received prior to the indicated deadlines.

* SIOP, IPSO and PROS Members: in order to apply for this category, please ensure your membership is approved and fees are paid for 2024 before you start the registration process. Registration will not be confirmed otherwise.
Important! In order to benefit from SIOP Membership reduced rate – please apply for membership at least 5 working days prior to registration deadline.
** Low-Income Countries registration fee refers to Low income and Lower-middle-income economies as listed here and defined according to the World Bank Country Classification. Click here to see the list of countries
*** Young SIOP Member- Young Investigators aged 40 or less.
****Students/Residents/Fellows-In order to benefit from the special fee, a submission of your status confirmation (approval letter signed by the Head of Department or copy of your status ID) must be uploaded during the online registration.
***** Psycho-social workers and Health care professionals

What the registration fees include (In-person participation):

• Access to all Sessions
• Invitation to the Opening Ceremony and Welcome Reception
• Access to the Exhibition and Poster Area
• Access to Meet the Expert Sessions, on a first come, first served basis
• Refreshments according to the congress timetable
• All sessions will be available on demand in the virtual platform for up to 3 months after the meeting

What the registration fees include (On-demand recording/Online participation):

• Open access to all presentations and session recordings.
• Earn CME credits. Be eligible to receive the number of CME credits attributed to the virtual meeting.
• Access all the e-posters. Browse research on the hottest topics published in the congress digital abstract book and connect with the abstract authors and other colleagues from around the world through the e-poster virtual consultations.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。